Moyamoya Disease risk factors in adults
Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing or occlusion of the internal carotid arteries and their main branches at the base of the brain. This constriction leads to the development of a network of tiny, fragile blood vessels that resemble a “puff of smoke” on imaging studies, which is what “moyamoya” means in Japanese. Although often diagnosed in children, adult cases are increasingly recognized, and understanding the risk factors in adults is crucial for early detection and management.
In adults, the risk factors for developing moyamoya disease are multifaceted and not entirely understood. Unlike some cerebrovascular conditions, moyamoya is not directly linked to traditional cardiovascular risk factors such as high cholesterol, hypertension, or smoking. Instead, its etiology appears to involve a complex interplay of genetic, environmental, and possibly autoimmune components.
Genetics play a significant role in moyamoya disease. Studies have identified specific genetic mutations, most notably in the RNF213 gene, that are associated with an increased risk of developing the disease. These genetic factors are particularly prevalent in East Asian populations, where the disease is more common. However, familial cases, where multiple family members are affected, suggest a hereditary component, making genetic counseling a consideration for affected individuals and their relatives.
Environmental factors and lifestyle choices may also influence the risk of moyamoya in adults, although the evidence remains limited. Some reports suggest that factors such as previous head trauma, radiation exposure, or certain infectious diseases might contribute to the disease’s onset or progression. However, these associations are not yet definitively established, and more research is needed to clarify their roles.
Autoimmune conditions have been observed in some adult cases of moyamoya disease. Diseases such as thyroiditis, rheumatoid arthritis, and systemic lupus erythematosus have been reported in conjunction with moyamoya, hinting at possible immune-mediated mechanisms. The presence of autoimmune disorders may predispose individuals to vascular inflammation and subsequent stenosis, which could accelerate the development of moyamoya vessels.
Other risk factors include age and gender. Moyamoya disease in adults tends to present around middle age, although it can occur at any adult stage. Some studies suggest a slight female predominance, but the gender difference is less pronounced compared to pediatric cases. Hormonal factors and gender-specific immune responses might influence susceptibility, although definitive conclusions are lacking.
In summary, the risk factors for moyamoya disease in adults are complex and encompass genetic predispositions, autoimmune conditions, and possibly environmental exposures. Since the disease can lead to serious complications such as strokes or transient ischemic attacks, recognizing these risk factors is vital for timely diagnosis and intervention. While some risk elements like genetics are non-modifiable, understanding them can help guide screening and management strategies, especially in high-risk populations or individuals with a family history.
Early detection and an individualized approach to treatment, which may include surgical revascularization procedures, can significantly improve outcomes for adults with moyamoya disease. Continued research into its risk factors and pathophysiology remains essential to better prevent and treat this challenging cerebrovascular disorder.
